Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.

Lauritzen B, Olling J, Abel KL, Augustsson C, Balling K, Bjelke M, Hegelund AC, Hilden I.

J Thromb Haemost. 2019 Mar;17(3):460-469. doi: 10.1111/jth.14380. Epub 2019 Feb 20.

PMID:
30614620
2.

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Augustsson C, Svensson A, Kjaer B, Chao TY, Wenjuan X, Krogh BO, Breinholt J, Clausen JT, Hilden I, Petersen HH, Petersen LC.

J Thromb Haemost. 2018 May;16(5):893-904. doi: 10.1111/jth.14000. Epub 2018 Apr 6.

PMID:
29532595
3.

The nanoparticle protein corona formed in human blood or human blood fractions.

Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, Cedervall T.

PLoS One. 2017 Apr 17;12(4):e0175871. doi: 10.1371/journal.pone.0175871. eCollection 2017.

4.

In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.

Augustsson C, Persson E.

Blood. 2014 Nov 13;124(20):3172-4. doi: 10.1182/blood-2014-05-576892. Epub 2014 Sep 16.

PMID:
25232061
5.

Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade.

Sanfins E, Augustsson C, Dahlbäck B, Linse S, Cedervall T.

Nano Lett. 2014 Aug 13;14(8):4736-44. doi: 10.1021/nl501863u. Epub 2014 Jul 21.

PMID:
25025946
6.

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Augustsson C, Hilden I, Petersen LC.

Thromb Res. 2014 Jul;134(1):132-7. doi: 10.1016/j.thromres.2014.03.043. Epub 2014 Apr 1.

PMID:
24787991

Supplemental Content

Loading ...
Support Center